Fingerprint
Dive into the research topics where Christine Kreher is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 6 Article
-
TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination
Kummer, L. Y., Kuijper, L. H., Fernández Blanco, L., Bos, A., Kreher, C., Verstegen, N. J., Duurland, M. C., Konijn, V. A., Jorritsma, T., Tempert, M., Menage, C., Steenhuis, M., Claireaux, M., Garcia-Vallejo, J. J., D'Haens, G. R., Löwenberg, M., Volkers, A. G., van Dam, K. P., Stalman, E. W. & Wieske, L. & 8 others, , 4 Aug 2025, In: RMD open. 11, 3, e005724.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile27 Downloads (Pure) -
Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID
Kummer, L. Y. L., Fernández Blanco, L., Kreher, C., Bos, A., Kuijper, L. H., Verstegen, N. J. M., van de Sandt, C. E., Konijn, V. A. L., Duurland, M. C., Menage, C., Jorritsma, T., Steenhuis, M., Hagen, R. R., van den Dijssel, J., de Jongh, R., Ashhurst, T., van Gils, M. J., Garcia-Vallejo, J. J., Claireaux, M. & Stalman, E. W. & 14 others, , 7 Oct 2024, In: RMD open. 10, 4Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile35 Downloads (Pure) -
mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses
van den Dijssel, J., Duurland, M. C., Konijn, V. A. L., Kummer, L. Y. L., Hagen, R. R., Kuijper, L. H., Wieske, L., van Dam, K. P. J., Stalman, E. W., Steenhuis, M., Geerdes, D. M., Mok, J. Y., Kragten, A. H. M., Menage, C., Koets, L., Veldhuisen, B., Verstegen, N. J. M., van der Schoot, C. E., van Esch, W. J. E. & D'Haens, G. R. A. & 10 others, , 1 Apr 2024, In: Journal of autoimmunity. 144, 103175.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile18 Downloads (Pure) -
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination
Verstegen, N. J. M., Hagen, R. R., Kreher, C., Kuijper, L. H., van den Dijssel, J., Ashhurst, T., Kummer, L. Y. L., Cabeza, V. P., Steenhuis, M., Duurland, M. C., de Jongh, R., van der Schoot, C. E., Konijn, V. A. L., Mul, E., Kedzierska, K., van Dam, K. P. J., Stalman, E. W., Boekel, L., Wolbink, G. & Tas, S. W. & 52 others, , 16 Aug 2024, In: Journal of Neurology, Neurosurgery and Psychiatry. 95, 9, p. 855-864 10 p., jnnp-2023-332224.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile27 Downloads (Pure) -
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies
T2B! immunity against SARS-CoV-2 study group, 1 Jun 2022, In: The Lancet Rheumatology. 4, 6, p. e417-e429Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1680 Downloads (Pure)